Skip to content

Medical-device intelligence

Becton Dickinson & Co: FDA clearances and recalls

Research Becton Dickinson & Co in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

196 clearance records and 250 recall records in the covered releases, across 1 source company names and 77 product codes. Dated history runs from Apr 12, 13 to Aug 13, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202501
November 202500
December 202500
January 202600
February 202600
March 202600
April 202602
May 202600
June 202600
July 202600
August 202602
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

446 matching records
Device / recordCompany in FDA recordSourceSource date
BD BACTEC FX, Instrument Top, Packaged Version or Model: 441385 Catalog Number: 441385Z-0593-2025 · MDBBecton Dickinson & Co.RecallDec 3, 2024FDA classification date
BD BACTEC FX40 Instrument Version or Model: 442296 Catalog Number: 442296Z-0594-2025 · MDBBecton Dickinson & Co.RecallDec 3, 2024FDA classification date
BACTEC 9120 System Version or Model: 445570 Catalog Number: 445570Z-0595-2025 · MDBBecton Dickinson & Co.RecallDec 3, 2024FDA classification date
BACTEC 9240 System Version or Model: 445475 Catalog Number: 445475Z-0596-2025 · MDBBecton Dickinson & Co.RecallDec 3, 2024FDA classification date
BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone laboratory software solution providing d…Z-0026-2025 · JQPBecton Dickinson & Co.RecallOct 8, 2024FDA classification date
BD Phoenix M50 instrument -Intended for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically significant ba…Z-3246-2024 · LONBecton Dickinson & Co.RecallSep 24, 2024FDA classification date
BD Phoenix 100-Intended for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically significant bacteria. The …Z-3247-2024 · LONBecton Dickinson & Co.RecallSep 24, 2024FDA classification date
BD BACTEC MGIT 960 PZA Kit)- IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culture to pyrazinamide (P…Z-2686-2024 · MJABecton Dickinson & Co.RecallAug 16, 2024FDA classification date
BD Kiestra Urine Culture Application Powered by BD Synapsys Informatics Solution; Catalog (Ref): 444900;Z-2585-2024 · KZBBecton Dickinson & Co.RecallAug 14, 2024FDA classification date
BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva s…Z-2023-2024 · QJRBecton Dickinson & Co.RecallJun 5, 2024FDA classification date
BD Phoenix NMIC-306 Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) polystyrene panel (tray) containing c…Z-1398-2024 · LONBecton Dickinson & Co.RecallMar 29, 2024FDA classification date
BD Phoenix Yeast ID Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) polystyrene panel (tray) containing c…Z-1399-2024 · LONBecton Dickinson & Co.RecallMar 29, 2024FDA classification date
Sensi Disc Amoxicillin with Clavulanic Acid 20/10 g, Catalog No. 231628 and 231629. These discs are used for semi-quantitative in vitro suscept…Z-1011-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ampicillin - 10 g, Catalog No. 230705 and 231264; 2 g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility t…Z-1012-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing.Z-1013-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Augmentin - 3g, Catalog Number 291270used for semi-quantitative in vitro susceptibility testing.Z-1014-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Azithromycin -15 g, Catalog Number 231682used for semi-quantitative in vitro susceptibility testing.Z-1015-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Aztreonam - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640and 231641.Z-1016-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefaclor - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653Z-1017-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefepime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696Z-1018-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefixime - 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664Z-1019-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefotaxime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607; 5 ug, Catalog…Z-1020-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 and 231674Z-1021-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231Z-1022-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632and 231633Z-1023-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗